Related Experiment Video
Updated: Oct 9, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Ischemic Stroke in a Patient with Stable CADASIL during COVID-19: A Case Report
Alessandro Cruciani1, Fabio Pilato1, Mariagrazia Rossi1
1Neurology, Neurophysiology and Neurobiology Unit, Department of Medicine, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Insights
COVID-19 infection may increase stroke risk in individuals with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This case highlights the heightened risk of ischemic stroke in CADASIL patients post-SARS-CoV-2 infection due to hypercoagulability.
Area of Science:
- Neurology
- Vascular Biology
- Infectious Diseases
Background:
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic small-vessel disease.
- CADASIL is characterized by recurrent ischemic stroke, cognitive decline, and mood disturbances, linked to endothelial dysfunction.
- SARS-CoV-2 infection is known to cause neurological complications, including stroke, and is associated with coagulopathy and endothelial dysfunction.
Observation:
- A patient with pre-existing CADASIL developed an acute ischemic stroke following SARS-CoV-2 infection.
- This case highlights a potential interaction between COVID-19 and CADASIL pathophysiology.
Findings:
- The combination of COVID-19-induced hypercoagulability and CADASIL-related endothelial dysfunction may significantly elevate the risk of ischemic stroke.
- SARS-CoV-2 infection can exacerbate the underlying vascular pathology in CADASIL patients.
Implications:
- Patients with endothelial dysregulation disorders like CADASIL may face an increased risk of stroke recurrence after COVID-19.
- This underscores the need for careful monitoring and management of cardiovascular risk in CADASIL patients during and after SARS-CoV-2 infection.
Background:
SARS-CoV-2 infection has been associated with different neurological conditions such as Guillain-Barré, encephalitis and stroke. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited small-vessel disease characterized by recurrent ischemic stroke, cognitive decline, migraine and mood disturbances. One of the mechanisms involved in CADASIL pathogenesis is endothelial dysfunction, which causes an increased risk of recurrent strokes. Since COVID-19 infection is also associated with coagulopathy and endothelial dysfunction, the risk of ischemic stroke might be even higher in this population. We describe the case of a CADASIL patient who developed an acute ischemic stroke after SARS-CoV-2 infection. In patients with diseases causing endothelial dysregulation, such as CADASIL, the hypercoagulability related to COVID-19 may contribute to the risk of stroke recurrence.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies